羅兵咸永道料本港全年有90至100隻新股上市 集資逾2,000億
羅兵咸永道指,2025年上半年香港IPO市場顯著回暖,共集資1,071億元,較去年同期上升7倍,躍居全球首位,為近十年來同期第二高,並已超越2024年全年集資額。
展望下半年,一向為香港IPO旺季,預期利好市場氣氛將延續。該行料下半年可繼續保持升勢,預測2025全年將有90至100家企業於香港上市,集資金額可望超過2,000億元。資訊科技及電訊服務、醫療和醫藥、以及零售、消費品及服務相關的行業板塊將會是市場焦點
該行指,目前已經遞交申請在香港上市的企業超過200家,涵蓋的企業來自不同行業,包括製造業、零售、消費品及服務等傳統行業,也有來自生物科技、醫療和醫藥、人工智能、資訊科技及電訊服務等新經濟行業。大型A股龍頭企業、中概股及海外企業亦積極赴港集資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.